Cargando…
Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA
BACKGROUND: BRCA1 and RASSF1A promoter methylation has been reported to be correlated with a worse survival in patients with breast cancer. However, the prognostic values of GSTP1, p16, ESR1, and PITX2 promoter methylation in breast cancer remain to be determined. Here, we performed this study to ev...
Autores principales: | Sheng, Xianneng, Guo, Yu, Lu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515759/ https://www.ncbi.nlm.nih.gov/pubmed/28700487 http://dx.doi.org/10.1097/MD.0000000000007476 |
Ejemplares similares
-
Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020) -
LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021) -
Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020) -
Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017) -
Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility: A meta-analysis
por: Liang, Xiong-Shun, et al.
Publicado: (2021)